Also trades as: AFT.NZ (NZE) · $vol 0M
AFP.AX ASX
AFT Pharmaceuticals Limited
1W: +0.3%
1M: -8.2%
3M: +14.6%
YTD: +6.8%
1Y: +43.8%
3Y: +12.0%
5Y: +52.6%
A$3.45 ($2.40)
+0.00 (+0.00%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
No convergence signal
Key Statistics
Market CapA$361.8M ($251.6M)
52W Range2.4-4.13
Volume2,981
Avg Volume2,083
Beta0.42
DividendA$0.02
Analyst Ratings
No analyst coverage
Company Info
CEOHartley Atkinson
Employees126
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2016-03-14
Websiteaftpharm.com
129 Hurstmere Road
Auckland, AUK 0622
NZ
Auckland, AUK 0622
NZ
64 9 488 0232
About AFT Pharmaceuticals Limited
AFT Pharmaceuticals Limited engages in the complete lifecycle of pharmaceutical products, from their initial development and licensing to their distribution and ultimate sale. The company's reach extends throughout New Zealand, Australia, Asia, and various other international markets. Its extensive product range encompasses treatments for allergies, cold and flu symptoms, ophthalmic conditions, first aid, pain management, digestive health, dermatological concerns, and medicated vitamin supplements. Established in 1997, AFT Pharmaceuticals has its corporate headquarters situated in Auckland, New Zealand.
Latest News
No recent news
Recent Insider Trades
No insider trades found